by Jordana Choucair | Mar 9, 2022 | Opioid/Substance Use Disorders
Insurers for some of the largest drug makers, distributors, and pharmacies are refusing to pay a $32 billion bill to help cover costs related to opioid addiction. A Delaware Supreme Court ruled in January that Chubb Ltd. didn’t have to pay to defend Rite Aid Corp....
by Jordana Choucair | Mar 8, 2022 | Opioid/Substance Use Disorders
Three congressmen unveiled new bipartisan legislation that would permanently ban illicit versions of fentanyl. Thus far, Congress has not acted on a long-term solution over concerns that a permanent ban could stifle scientific research into fentanyl analogues and the...
by Jordana Choucair | Mar 4, 2022 | Opioid/Substance Use Disorders
OxyContin maker Purdue Pharma and the Sackler family have struck an agreement to pay up to $6 billion to settle lawsuits over the company’s role in fueling the opioid crisis. The new settlement is up from the $4.55 deal reached last year and is contingent upon...
by Jordana Choucair | Mar 2, 2022 | Opioid/Substance Use Disorders
Supreme Court justices struggled to define a legal standard to parse out unusual medical practices from drug dealing as they considered the cases of two doctors who were convicted of unlawful drug distribution. The justices deliberated how to read a phrase in a...
by Jordana Choucair | Mar 1, 2022 | Opioid/Substance Use Disorders
Lawyers for two doctors convicted of illegal opioid prescribing will ask the Supreme Court to overturn the doctors’ convictions and establish a standard that allows doctors to raise a “good faith” defense. Juries could then consider whether doctors...
by Jordana Choucair | Feb 25, 2022 | Opioid/Substance Use Disorders
Drugmaker Johnson & Johnson and three major distributors –AmerisourceBergen Corp., McKesson Corp., and Cardinal Health Inc. – finalized a $26 billion settlement with states and local governments over their role in the opioid epidemic. The nationwide settlements...
Recent Comments